Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FNS who wrote (766)	8/24/1998 10:58:00 AM
From: Mark T Warren	Read Replies (1) of 965

Seems like CNTO should be rising faster than it is. Look at all the good news today: Six-Month Data Show Use of ReoPro(R) with Stents Provides Sustained Cardiac Benefits, Cutting Death or Heart Attack in Half Centocor Inc. (CNTO) Biotech shares reiterated "strong buy" at Prudential Securities after company reported positive data from coronary stent trial. Prudential expects stock to hit $70 within the next twelve months. Centocor Inc. (CNTO) 38 7/8 +1 1/8: --UPDATE-- Morgan Stanley Dean Witter reiterates "strong buy" rating on biopharmaceutical company after it releases ReoPro study..... FDA Approves Centocor's REMICADE(TM) to Treat Crohn's Disease; First New Product in 30 Years Indicated for This Serious Gastrointestinal Condition I thought it would be flying. Maybe this is the start.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next